Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition. From almost 7,000 applicants, RTI was reviewed and was selected to be among the 113 top entries.
Raland Therapeutics Inc. held its first in-person board meeting last weekend, drawing a cast of luminaries to the startup biotech firm’s Perinton headquarters.
Efferent Labs® offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Sign up for email alerts of Press Releases and Efferent Labs’ breaking news
